Grafa makes finance simple and entertaining. It allows anyone, anywhere in the world to quickly research, get tips and understand investment opportunities.
Safety Profile
Grafa topics
Grafa
03/10/2024
Abivax's Obefazimod shows promise in ulcerative colitis maintenance study
Grafa
12/09/2024
GSK's mRNA flu vaccine shows promise in phase II trial
Grafa
08/07/2024
IDEAYA Biosciences (NASDAQ:IDYA) shows strong phase 2 IDE397 results
Grafa
25/06/2024
AstraZeneca (NASDAQ:AZN) faces setback as Imfinzi trial misses goal
Grafa
18/06/2024
Taysha Gene Therapies (NASDAQ:TSHA) reports positive Rett Syndrome trial data
Grafa
14/05/2024
Pliant Therapeutics (NASDAQ:PLRX) unveils breakthrough IPF drug results
Grafa
20/03/2024
ACELYRIN (NASDAQ:SLRN) unveils breakthrough in TED therapy
Grafa
13/12/2023
Syntara (ASX:SNT) begins final cohort dosing in Phase 2 Myelofibrosis trial
Hub
News
Watchlist
Hot
Markets